From BigGo Finance · BigGo Finance · · 1m 10s
TL;DR: Hana Securities Targets Celltrion at 310,000 Won
Hana Securities boosts Celltrion stock with 310,000 won target, betting on U.S. biosimilar sales growth.
Hana Securities initiates Celltrion coverage with a 310,000 won target, citing U.S. biosimilar sales as growth driver. Hana Securities boosts Celltrion stock with 310,000 won target, betting on U.S. biosimilar sales growth. Hana Securities has initiated coverage on South Korea's Celltrion with a 'Buy' rating and a target price of 310,000 won.
- Hana Securities Initiates Coverage
- Q3 Revenue and Profit Growth
- U.S. Direct Sales Catalyst
- Full-Year Projections
Read the story version — the same reporting as a swipeable deck of 7 cards.






